The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ASTR, ERIC and AKBA

NEW YORK, NY / ACCESSWIRE / April 4, 2022 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

Astra Space Inc. f/k/a Holicity Inc. ASTR
Class Period: February 2, 2021 - December 29, 2021
Lead Plaintiff Deadline: April 11, 2022

The ASTR lawsuit alleges Astra Space Inc. f/k/a Holicity Inc. made materially false and/or misleading statements and/or failed to disclose during the class period that: (1) Astra cannot launch "anywhere"; (2) Astra significantly overstated its addressable market; (3) Astra overstated the effectiveness of its designs and reliability; (4) Astra significantly overstated its plans for diversification and its broadband constellation plan; and (5) as a result, Defendants' public statements were materially false and/or misleading at all relevant times.

Learn about your recoverable losses in ASTR: https://www.kleinstocklaw.com/pslra-1/astra-space-inc-f-k-a-holicity-inc-loss-submission-form?id=25533&from=1

Telefonaktiebolaget LM Ericsson ERIC
Class Period: April 27, 2017 - February 25, 2022
Lead Plaintiff Deadline: May 2, 2022

The complaint alleges that during the class period Telefonaktiebolaget LM Ericsson made materially false and/or misleading statements and/or failed to disclose that: (i) Ericsson overstated the extent to which it had reformed its business practices to eliminate the use of bribes to secure business in foreign countries; (ii) Ericsson had paid bribes to the terrorist group the Islamic State in Iraq and Syria to gain access to certain transport routes in Iraq; (iii) accordingly, the Company's revenues derived from its operations in Iraq were, in at least substantial part, derived from unlawful conduct and thus unsustainable; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

Learn about your recoverable losses in ERIC: https://www.kleinstocklaw.com/pslra-1/telefonaktiebolaget-lm-ericsson-loss-submission-form?id=25533&from=1

Akebia Therapeutics, Inc. AKBA
Class Period: June 28, 2018 - September 2, 2020
Lead Plaintiff Deadline: May 13, 2022

Throughout the class period, Akebia Therapeutics, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (i) the Company's lead investigational product candidate, vadadustat, was not as safe in treating non-dialysis dependent chronic kidney disease patients with anemia as defendants had represented; (ii) as a result, defendants overstated the clinical prospects of a Phase 3 clinical program for vadadustat; (iii) accordingly, defendants also overstated vadadustat's overall commercial and regulatory prospects; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

Learn about your recoverable losses in AKBA: https://www.kleinstocklaw.com/pslra-1/akebia-therapeutics-inc-loss-submission-form?id=25533&from=1

Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

SOURCE : The Klein Law Firm